What is microdosing psychedelics and what does current evidence suggest about benefits and risks?

• A. Taking high-dose psychedelic.
• B. Microdosing is banned.
• C. Using psychedelics to cure addiction.
• D. Taking sub-perceptual doses; claimed mood/cognition benefits; evidence limited; risks include anxiety, mood changes, and legal issues.

Answer: (D)

Microdosing involves taking very small amounts of a psychedelic drug, such as LSD or psilocybin, that are below the level needed to produce noticeable psychedelic effects. People do this on a set schedule hoping for mood, energy, or cognitive benefits without a full-blown trip.

Current evidence does not show strong, consistent benefits. Much of what is reported anecdotally could be due to placebo effects or expectations, and high-quality studies have produced mixed or largely inconclusive results. In short, any improvements found are modest and not reliably replicated across research.

Risks include anxiety or mood changes, especially in people with a history of mood or psychotic disorders, as well as sleep disturbances or other mood fluctuations. There are also legal considerations and potential safety issues from inconsistent dosing or contaminated substances.